UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery

Journal of personalized medicine, 2021-02, Vol.11 (2), p.115

2021

Volltextzugriff (PDF)

Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment

Pharmaceutics, 2019-09, Vol.11 (9), p.471

2019

Volltextzugriff (PDF)

Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid

Molecular pharmaceutics, 2019-08, Vol.16 (8), p.3452-3459

2019

Volltextzugriff (PDF)

Hydrolytically Degradable Polymer Micelles for Drug Delivery: A SAXS/SANS Kinetic Study

Biomacromolecules, 2013-11, Vol.14 (11), p.4061-4070

2013

Volltextzugriff (PDF)

Cross-Linking Effects Dictate the Preference of Galectins to Bind LacNAc-Decorated HPMA Copolymers

International journal of molecular sciences, 2021-06, Vol.22 (11), p.6000

2021

Volltextzugriff (PDF)

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy

Pharmaceutics, 2021-01, Vol.13 (2), p.179

2021

Volltextzugriff (PDF)

Molecular Mechanisms of the Interactions of N -(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins

Pharmaceutics, 2020-01, Vol.12 (2), p.106

2020

Volltextzugriff (PDF)

HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study

International journal of pharmaceutics, 2018-01, Vol.536 (1), p.108-115

2018

Volltextzugriff (PDF)

Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization

Acta biomaterialia, 2020-04, Vol.106, p.256-266

2020

Volltextzugriff (PDF)

Polymer‐Based Drug‐Free Therapeutics for Anticancer, Anti‐Inflammatory, and Antibacterial Treatment

Macromolecular bioscience, 2021-08, Vol.21 (8), p.n/a

2021

Volltextzugriff (PDF)

Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties

Journal of controlled release, 2020-05, Vol.321, p.718-733

2020

Volltextzugriff (PDF)

N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation

European journal of pharmaceutical sciences, 2010-11, Vol.41 (3), p.473-482

2010

Volltextzugriff (PDF)

Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation

International journal of pharmaceutics, 2024-08, Vol.661, p.124465, Article 124465

2024

Volltextzugriff (PDF)

Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging

Journal of controlled release, 2018-11, Vol.289, p.44-55

2018

Volltextzugriff (PDF)

Happy Birthday Karel

Macromolecular bioscience, 2018-01, Vol.18 (1), p.n/a

2018

Volltextzugriff (PDF)

The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia

Journal of controlled release, 2016-02, Vol.223, p.1-10

2016

Volltextzugriff (PDF)

Glycopolymers for Efficient Inhibition of Galectin-3: In Vitro Proof of Efficacy Using Suppression of T Lymphocyte Apoptosis and Tumor Cell Migration

Biomacromolecules, 2020-08, Vol.21 (8), p.3122-3133

2020

Volltextzugriff (PDF)

Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting

European journal of pharmaceutical sciences, 2011-04, Vol.42 (5), p.527-539

2011

Volltextzugriff (PDF)

Hydrolytically Degradable Polymer Micelles for Anticancer Drug Delivery to Solid Tumors

Macromolecular chemistry and physics, 2012-04, Vol.213 (8), p.858-867

2012

Volltextzugriff (PDF)

Glycopolymers Decorated with 3- O -Substituted Thiodigalactosides as Potent Multivalent Inhibitors of Galectin-3

Journal of medicinal chemistry, 2022-03, Vol.65 (5), p.3866-3878

2022

Volltextzugriff (PDF)

High-Affinity N‑(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N‑Acetyllactosamine Presentation Discriminate between Galectins

Biomacromolecules, 2020-02, Vol.21 (2), p.641-652

2020

Volltextzugriff (PDF)

Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer–Doxorubicin Drug Conjugates with pH-Triggered Drug Release

Molecular pharmaceutics, 2018-09, Vol.15 (9), p.3654-3663

2018

Volltextzugriff (PDF)

Highly hydrophilic methacrylamide-based copolymers as precursors for polymeric nanomedicines containing anthracyclines

European polymer journal, 2024-02, Vol.205, p.112756, Article 112756

2024

Volltextzugriff (PDF)

Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester

Journal of controlled release, 2013-01, Vol.165 (2), p.153-161

2013

Volltextzugriff (PDF)

N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation

Journal of applied polymer science, 2008-09, Vol.109 (5), p.3050-3061

2008

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(47)
Buchkapitel
(3)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery

Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment

Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid

Hydrolytically Degradable Polymer Micelles for Drug Delivery: A SAXS/SANS Kinetic Study

Cross-Linking Effects Dictate the Preference of Galectins to Bind LacNAc-Decorated HPMA Copolymers

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy

Molecular Mechanisms of the Interactions of N -(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins

HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study

Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization

Polymer‐Based Drug‐Free Therapeutics for Anticancer, Anti‐Inflammatory, and Antibacterial Treatment

Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties

N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation

Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation

Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging

Happy Birthday Karel

The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia

Glycopolymers for Efficient Inhibition of Galectin-3: In Vitro Proof of Efficacy Using Suppression of T Lymphocyte Apoptosis and Tumor Cell Migration

Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting

Hydrolytically Degradable Polymer Micelles for Anticancer Drug Delivery to Solid Tumors

Glycopolymers Decorated with 3- O -Substituted Thiodigalactosides as Potent Multivalent Inhibitors of Galectin-3

High-Affinity N‑(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N‑Acetyllactosamine Presentation Discriminate between Galectins

Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer–Doxorubicin Drug Conjugates with pH-Triggered Drug Release

Highly hydrophilic methacrylamide-based copolymers as precursors for polymeric nanomedicines containing anthracyclines

Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester

N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation

Aktive Filter

Suchergebnisse filtern